Skip to Main Content

Author Details

Ian Dunham
European Bioinformatics Institute (EMBL-EBI)
1987
175
64
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36399499The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.Nucleic Acids Res2023
36399499The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.Nucleic Acids Res2023
37749083Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.Sci Data2023
37609366Sex difference contributes to phenotypic diversity in individuals with neurodevelopmental disorders.Front Pediatr2023
37337100Democratizing knowledge representation with BioCypher.Nat Biotechnol2023
36963162Future prospects for human genetics and genomics in drug discovery.Curr Opin Struct Biol2023
37749083Integrative GWAS and co-localisation analysis suggests novel genes associated with age-related multimorbidity.Sci Data2023
37609366Sex difference contributes to phenotypic diversity in individuals with neurodevelopmental disorders.Front Pediatr2023
37337100Democratizing knowledge representation with BioCypher.Nat Biotechnol2023
36963162Future prospects for human genetics and genomics in drug discovery.Curr Opin Struct Biol2023
34996498Integrative analysis of 3604 GWAS reveals multiple novel cell type-specific regulatory associations.Genome Biol2022
35772218Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.EBioMedicine2022
35568032Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites.Am J Hum Genet2022
35804044Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.Nat Rev Drug Discov2022
34996498Integrative analysis of 3604 GWAS reveals multiple novel cell type-specific regulatory associations.Genome Biol2022
35804044Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs.Nat Rev Drug Discov2022
35772218Multi-ancestry Mendelian randomization of omics traits revealing drug targets of COVID-19 severity.EBioMedicine2022
35568032Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites.Am J Hum Genet2022
33045747Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.Nucleic Acids Res2021
34285415The PROTACtable genome.Nat Rev Drug Discov2021
33045747Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.Nucleic Acids Res2021
33196847Open Targets Platform: supporting systematic drug-target identification and prioritisation.Nucleic Acids Res2021
34402426A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.Elife2021
34711957An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.Nat Genet2021
34402426A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance.Elife2021
34711957An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci.Nat Genet2021
34285415The PROTACtable genome.Nat Rev Drug Discov2021
33196847Open Targets Platform: supporting systematic drug-target identification and prioritisation.Nucleic Acids Res2021
33289971Mining a GWAS of Severe Covid-19.N Engl J Med2020
31930349The open targets post-GWAS analysis pipeline.Bioinformatics2020
33289972Mining a GWAS of Severe Covid-19.N Engl J Med2020
33289971Mining a GWAS of Severe Covid-19.N Engl J Med2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
31930349The open targets post-GWAS analysis pipeline.Bioinformatics2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33289972Mining a GWAS of Severe Covid-19.N Engl J Med2020
30692680GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals.Nat Genet2019
30462303Open Targets Platform: new developments and updates two years on.Nucleic Acids Res2019
30976107Applications of machine learning in drug discovery and development.Nat Rev Drug Discov2019
30692680GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals.Nat Genet2019
31161210eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.Bioinformatics2019
30976107Applications of machine learning in drug discovery and development.Nat Rev Drug Discov2019
31161210eFORGE v2.0: updated analysis of cell type-specific signal in epigenomic data.Bioinformatics2019
30462303Open Targets Platform: new developments and updates two years on.Nucleic Acids Res2019
29229604Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer.Cancer Res2018
30256779Human genes: Time to follow the roads less traveled?PLoS Biol2018
30439935Ten simple rules for delivering live distance training in bioinformatics across the globe using webinars.PLoS Comput Biol2018
30293088The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.Nat Rev Cancer2018
30285606Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands.BMC Bioinformatics2018
29229604Transcription Factor Activities Enhance Markers of Drug Sensitivity in Cancer.Cancer Res2018
  • 1 - 50 of 350

Recommended Authors

Martin S Taylor
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2000
Number of shared co-authors 59
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 19
Alexandre Montpetit
McGill University and Genome Quebec Innovation Centre
Career Start Year 1998
Number of shared co-authors 69
Adam Pavlicek
Monoceros Biosystems LLC
Career Start Year 1998
Number of shared co-authors 1
Colin A Semple
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 1997
Number of shared co-authors 26
Jay Shendure
University of Washington
Career Start Year 1996
Number of shared co-authors 60
Jared C Roach
Institute for Systems Biology
Career Start Year 1995
Number of shared co-authors 9
Alejandro A Sch??ffer
National Cancer Institute, National Institutes of Health
Career Start Year 1993
Number of shared co-authors 10
Kimberly F Doheny
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Career Start Year 1993
Number of shared co-authors 42
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Career Start Year 1992
Number of shared co-authors 21
Arnaud Gos
Centre Medical Universitaire
Career Start Year 1992
Number of shared co-authors 5
Samuel Levy
Bluestar Genomics Inc.
Career Start Year 1991
Number of shared co-authors 12
Francisco M De La Vega
Stanford University School of Medicine
Career Start Year 1991
Number of shared co-authors 14
Christopher J Porter
Ottawa Hospital Research Institute
Career Start Year 1990
Number of shared co-authors 0
Anthony J Brookes
University of Leicester
Career Start Year 1989
Number of shared co-authors 54
Gustavo Glusman
Institute for Systems Biology
Career Start Year 1988
Number of shared co-authors 63
Juha Kere
Folkhalsan Research Center, University of Helsinki
Career Start Year 1987
Number of shared co-authors 40
Pui-Yan Kwok
Cardiovascular Research Institute, University of California San Francisco
Career Start Year 1987
Number of shared co-authors 93
Andreas Gnirke
The Center for Genome Architecture, Baylor College of Medicine
Career Start Year 1986
Number of shared co-authors 41
David N Cooper
Institute of Medical Genetics, Cardiff University
Career Start Year 1983
Number of shared co-authors 73
Johan T den Dunnen
Leiden University Medical Center
Career Start Year 1982
Number of shared co-authors 28
Peter K Rogan
CytoGnomix Inc.
Career Start Year 1981
Number of shared co-authors 1
Michael Dean
National Cancer Institute
Career Start Year 1980
Number of shared co-authors 29
Aravinda Chakravarti
New York University Grossman School of Medicine
Career Start Year 1977
Number of shared co-authors 120
Donna R Maglott
National Center for Biotechnology Information, National Institutes of Health
Career Start Year 1976
Number of shared co-authors 82
Deborah A Nickerson
University of Washington
Career Start Year 1976
Number of shared co-authors 89
Mark Lathrop
Victor Philip Dahdaleh Institute of Genomic Medicine at McGill University
Career Start Year 1975
Number of shared co-authors 85
Alan F Scott
Johns Hopkins University School of Medicine
Career Start Year 1972
Number of shared co-authors 12
Mark F Leppert
University of Utah
Career Start Year 1968
Number of shared co-authors 65
Kelly A Frazer
University of California, USA Institute for Genomic Medicine
Career Start Year 1967
Number of shared co-authors 73

Collaborators

Andrew J Mungall
Co-authored papers 22
Ewan Birney
European Bioinformatics Institute
Co-authored papers 21
David R Bentley
Illumina Cambridge Ltd.
Co-authored papers 19
Nigel P Carter
4Wellcome Trust Sanger Institute
Co-authored papers 17
Jane Rogers
The Wellcome Trust Sanger Institute
Co-authored papers 16
Cordelia Langford
Co-authored papers 16
Stephan Beck
UCL Cancer Institute, University College London
Co-authored papers 15
David M Beare
Co-authored papers 14
Christof Koch
Co-authored papers 14
Sarah E Hunt
European Bioinformatics Institute
Co-authored papers 13
Tim Hubbard
Co-authored papers 12
Panos Deloukas
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 11
Maya Ghoussaini
Wellcome Sanger Institute
Co-authored papers 11
Pawandeep Dhami
Co-authored papers 11
Richard Durbin
University of Cambridge
Co-authored papers 11
Chris Clee
Co-authored papers 10
Paul Flicek
European Bioinformatics Institute
Co-authored papers 10
Sean Humphray
Illumina Ltd.
Co-authored papers 10
Mark T Ross
Illumina Cambridge Ltd.
Co-authored papers 8
Lucy Matthews
University of Oxford
Co-authored papers 8
Stephen M J Searle
Wellcome Trust Sanger Institute
Co-authored papers 8
John A Stamatoyannopoulos
Altius Institute for Biomedical Sciences
Co-authored papers 7
David Vetrie
Co-authored papers 7
David Willey
Institute of Biotechnology, University of Cambridge
Co-authored papers 6
Eric D Green
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 6
Gayle K Clelland
Co-authored papers 6
Catherine M Rice
Co-authored papers 6
Sarah Sims
Co-authored papers 6
Richard M Myers
HudsonAlpha Institute for Biotechnology
Co-authored papers 6
Jason D Lieb
The University of Chicago
Co-authored papers 6
Release 1.2